Dose once or twice daily with precision application¹

OXISTAT Lotion is available in 2 bottle sizes: 30 mL and 60 mL.

OXISTAT Lotion 30 mL features the convenient interdigital applicator for PRECISION APPLICATION

Helps minimize waste
Precludes the need for patients to touch the affected area during application

OXISTAT® (oxiconazole nitrate) Lotion 30 mL bottle with interdigital applicator

Prescribe OXISTAT Lotion by name! To help ensure your patients receive the treatment you prescribed, specify “OXISTAT Lotion” and DAW or DNS.*

* Dispense as written (DAW), do not substitute (DNS), or equivalent language in your state.

Reference: 1. OXISTAT Lotion Prescribing Information; July 2022.

Important Safety Information

For topical dermatologic use only. Not for oral, ophthalmic, or intravaginal use.

OXISTAT^® (oxiconazole nitrate) Lotion is contraindicated in individuals who have shown hypersensitivity to any of its components. If a reaction suggesting sensitivity or chemical irritation should occur with the use of OXISTAT Lotion, treatment should be discontinued and appropriate therapy instituted. If signs of epidermal irritation should occur, the drug should be discontinued.

In a clinical trial with OXISTAT Lotion (N=269), the most common adverse events were burning and stinging (0.7% each) and pruritus, scaling, tingling, pain and dyshidrotic eczema (0.4% each).

The following additional adverse experiences have been reported with the topical use of oxiconazole nitrate: irritation and allergic contact dermatitis, folliculitis, erythema, papules, fissure, maceration, rash, and nodules.

You are encouraged to report negative side effects of prescription drugs to the FDA. Please visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication

OXISTAT Lotion is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum.

Click here to see full Prescribing Information.

The information on this site is intended for U.S. residents only.
OXISTAT^® is a registered trademark of Fougera Pharmaceuticals, Inc.
© 2023 ANI Pharmaceuticals, Inc. All rights reserved.

Site Map | Terms of Use | Privacy Policy | ANI Pharmaceuticals, Inc

The information on this site is intended for U.S. residents only.
10470 Rev 03/23

Dose once or twice daily with precision application1

Important Safety Information

Indication

Dose once or twice daily with precision application¹